Lipoxin A 4 and 8-isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus

Pediatric Critical Care Medicine

Volumn 13, Issue 2, 2012, Pages 141-145

  Hasan, Rashed A ^a   O'Brien, Edmund ^b   Mancuso, Peter ^b  

^a PROVIDENCE HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

asthma; child; lipoxins

Indexed keywords

8 ISOPROSTANE; LIPOXIN A; METHYLPREDNISOLONE; SALBUTAMOL;

ADOLESCENT; ARTICLE; ASTHMATIC STATE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXHALATION; EXHALED BREATH CONDENSATE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; BREATH TESTS; CASE-CONTROL STUDIES; CHILD; DINOPROST; EXHALATION; FEMALE; HOSPITALIZATION; HUMANS; LIPOXINS; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; STATUS ASTHMATICUS; TIME FACTORS;

EID: 84858253670     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3182231644     Document Type: Article

References (29)

1. Serhan CN, Clish CB, Brannon CJ, et al: Novel functional sets of lipid-derived mediators with anti-inflammatory actions generated from omega-3-fatty acids via cycloxygenase 2-non-steroidal anti-inflammatory drugs and transcellular processing. J Exp Med 2000; 192:1197-1204
2. Serhan CN: Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007; 25:101-137
3. Levy BD, Kohli P, Gotlinger K, et al: Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol 2007; 178:496-502 (Pubitemid 46039663)
4. Levy BD, Lukaacs NE, Berlin AA, et al: Lipoxin A4 stable analogs reduce allergic airway response via mechanisms distinct from CysLT1 antagonism. FASEB J 2007; 21: 3877-3884 (Pubitemid 350232345)
5. Levy BD, De Sanctis GT, Devchand PR, et al: Multi-pronged inhibition of airway hyperresponsiveness and inflammation by lipoxin A4. Nat Med 2002; 8:1018-1023 (Pubitemid 35033707)
6. Godson C, Mitchell S, Harvey K, et al: Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 2000; 164:1663-1667 (Pubitemid 30108713)
7. Sanak M, Levy BD, Clish CB, et al: Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 2000; 16:44-49 (Pubitemid 30480126)
8. Levy BD, Bonnans C, Silverman ES, et al: Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 2005; 172:824-830 (Pubitemid 41369064)
9. Planaguma A, Kazani S, Marigowda G, et al: Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008; 178:574-582
10. Tahan F, Saraymen R, Gumus H: The role of lipoxin A4 in exercise-induced broncho-constriction in asthma. J Asthma 2008; 45: 161-164 (Pubitemid 351416970)
11. Wu SH, Yin PL, Zhang YM, et al: Reversed changes of lipoxin A4 and leukotrienes in children with asthma of different severity degree. Pediatr Pulmonol 2010; 45:333-340
12. Prieto L, Ferrer A, Palop J, et al: Differences in exhaled breath condensate pH measurement between samples obtained with two commercial devices. Respir Med 2007; 101: 1715-1720 (Pubitemid 46930710)
13. Kharitonov SA, Barnes PJ: Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163:1693-1722 (Pubitemid 32578777)
14. Hunt JF, Fong Km Malik R, et al: Endogenous airway acidification: Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000; 161:694-699 (Pubitemid 30171718)
15. Baraldi E, Carraro S, Alinovi R, et al: Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003; 58:505-509 (Pubitemid 36714012)
16. Montuschi P, Corradi M, Ciabattoni G, et al: Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160:216-220 (Pubitemid 29326091)
17. National Heart, Lung, and Blood Institute: Global Initiative for Asthma; Global Strategy. National Heart, Lung, and Blood Institute. Global Initiative for Asthma; Global Strategy for Asthma Management and Prevention; NHLBI/WHO Workshop Report. Bethesda, MD, National Institute of Health, 2006. Publication No. 02-3659
18. Wood DW, Downes JJ, Leck HI: A clinical scoring system for the diagnoses of respiratory failure. Am J Dis Child 1972; 123: 227-228
19. Becker AB, Nelson NA, Simons ER: The pulmonary index: Assessment of a clinical score for asthma. Am J Dis Child 1984; 138: 574-576 (Pubitemid 14100983)
20. Hasan RA, Thomas J, Davidson B, et al: 8-Isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus. Pediatr Crit Care Med 2010; 12:e25-28
21. Horvath I, Hunt J, Barnes PJ: Exhaled breath condensate: Methodological recommendations and unanswered questions. Eur Respir J 2005; 26:523-548 (Pubitemid 41264218)
22. Peters-Golden M, Shelley CJ: Inhibitory effects of exogenous arachidonic acid on alveolar macrophage 5-lipoxygenase metabolism- role of ATP depletion. J Immunol 1988; 140:1958-1966
23. Barreto M, Villa MP, Olita C, et al: 8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents. Chest 2009; 135:66-73
24. Levy BD, Clish CB, Schmidt B, et al: Lipid mediator class switching during acute inflammation: Signals in resolution. Nat Immunol 2001; 2:612-619 (Pubitemid 32677628)
25. Jozsef L, Zouki C, Petasis NA, et al: Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc Nat Acad Sci U S A 2002; 99:13266-13271
26. Gagliardo R, Chanez P, Mathieu M, et al: Persistent activation of nuclear factor-κB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med 2003; 168:1190-1198 (Pubitemid 37424040)
27. Serhan CN, Jain A, Marleau S, et al: Reduced inflammation and tissue damage in transgenic rabbits over expressing 15- lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003; 171:6856 - 6865
28. Conrad DJ, Dai X: Murine 12/15-lipoxygenase (12/15-LO) inhibits antigen-dependent airway inflammation and has a distinct pattern of tissue expression. Am J Resp Crit Care Med 2002; 165:B46
29. Bhavsar PK, Levy BD, Hew MK, et al: Corticosteroid suppression of lipoxin A4 and leukotrienes B4 from alveolar macrophages in severe asthma. Respir Res 2010; 11:71